HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Nanoparticles Screening; ICCR Prep; Nu Skin China; Unilever Q1

This article was originally published in The Rose Sheet

Executive Summary

A study published in ACS Nano demonstrates that uncoated zinc oxide and silver nanoparticles damage DNA; investigators say their screening platform based on CometChip technology can help in the development of safer-by-design approaches. More news in brief.

You may also be interested in...



China Probe Finds Issues With Nu Skin Compliance, Not Business Model

Nu Skin’s direct-selling model in China, the legality of which some investors have questioned, was not cited in fines levied on the company totaling $540,000. Firm says it “is not aware of any other material enforcement investigations currently pending” in the country, which accounted for nearly half of Nu Skin’s fiscal 2013 fourth-quarter sales.

ICCR Addresses Lead Limit, Endocrine Disruptors At 7th Meeting

Regulators from the US, Canada, Japan and the EU met in Tokyo July 8-10 for the seventh annual meeting of the International Cooperation on Cosmetics Regulation. The group agreed to recommend a 10-ppm limit on lead in cosmetic products.

US FDA Facility Compliance Actions Could Speed Up Despite Inspections Freeze, Attorney Says

With inspectors no longer out in the field, they have more time to wrap up work on previously completed facility evaluations, attorney Howard Sklamberg says; inspections freeze could delay manufacturers’ abilities to bring facilities into compliance following adverse inspection findings, as well as agency reclassifications of facility status.

Related Companies

UsernamePublicRestriction

Register

RS019001

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel